位置：成果数据库 > 期刊 > 期刊详情页
Integrating interacting drugs and genetic variations to improve the predictability of warfarin maint
  • ISSN号：1744-6872
  • 期刊名称：Pharmacogenetics and Genomics
  • 时间：2012.3.3
  • 页码：176-182
  • 相关项目：基于DNA pooling的全基因组筛选PCI术后抗血小板治疗效应的遗传标记及评价
作者： Zhong, Shi-Long|Yu, Xi-Yong|Liu, Yuan|Xu, Dan|Mai, Li-Ping|Tan, Hong-Hong|Lin, Qiu-Xiong|Yang, Min|Lin, Shu-Guang|
同期刊论文项目
基于DNA pooling的全基因组筛选PCI术后抗血小板治疗效应的遗传标记及评价
期刊论文 16 会议论文 6
同项目期刊论文
Association of PON1 genotype and haplotype with susceptibility to coronary artery disease and clinic
经皮冠状动脉介入治疗术后支架内再狭窄的遗传学与表观遗传学研究进展
Pharmacokinetics, excretion, and distribution of combretastatin A4 phosphate in rats
ADRB2 Gln27Glu基因多态性对经皮冠状动脉介入术后β受体阻滞剂临床疗效的影响
The influence of genetic polymorphisms and interacting drugs on initial response to warfarin in Chin
血浆循环MicroRNA提取检测及其在冠心病的表达
基因组水平筛选冠状动脉病变部位参与急性心肌梗死急性期的信号通路
用权重基因共表达网络分析识别心脏重构关键节点基因
PON1基因启动子多态性及非遗传因素对PCI术后抗血小板治疗临床效应的影响
A metagenome-wide association study of gut microbiota in type 2 diabetes
Serum metabolomics reveals lipid metabolism variation between coronary artery disease and congestive
Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in
Association of β-adrenergic receptor genes polymorphisms with incidence of subsequent cardiovas
主动脉夹层与肌球蛋白重链11基因多态性的关系
Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-tr